Literature DB >> 19940934

Rapid method for extracting the antibiotic mutacin 1140 from complex fermentation medium yeast extract.

Noel Chaney1, Shawanda Wilson-Stanford, James Kastrantas, Neeti Dahal, Leif Smith.   

Abstract

The peptide antibiotic mutacin 1140 belongs to the group of antibiotics called lantibiotics. They are ribosomally synthesized and undergo extensive enzymatic modifications before being excreted into the culture medium. By using reverse-phase-high-performance liquid chromatography (RP-HPLC) and a semiquantitative bacteriocin bioassay to track mutacin 1140, an efficient ammonium sulfate (AS) precipitation method has been developed for removing mutacin 1140 from a complex medium containing 5% yeast extract. This method minimizes the amounts of fermentation by-products and media components that make downstream purification processes more difficult and economically infeasible. The method may be adaptable for the initial purification step of other lantibiotics. A threefold decrease in the precipitation of the medium components found in yeast extract, at pH 8.0 vs. pH 2.0, may have broad utility for the isolation of secondary metabolites produced in this complex medium. The average yield of mutacin 1140 from the fermentation medium was determined as 66%.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940934     DOI: 10.1139/w09-091

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  6 in total

1.  Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.

Authors:  Adam Pepperney; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

2.  Optimization of the Production of the Lantibiotic Mutacin 1140 in Minimal Media.

Authors:  Dahal Neeti; Chaney Noel; Ellis Dayna; Lu Shi-En; Smith Leif
Journal:  Process Biochem       Date:  2010-07-01       Impact factor: 3.757

3.  Site-directed mutations in the lanthipeptide mutacin 1140.

Authors:  Shaorong Chen; Shawanda Wilson-Stanford; William Cromwell; Jeffrey D Hillman; Adam Guerrero; Charlotte A Allen; Joseph A Sorg; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

4.  Bioprocess Development for Lantibiotic Ruminococcin-A Production in Escherichia coli and Kinetic Insights Into LanM Enzymes Catalysis.

Authors:  Elvis L Ongey; Lara Santolin; Saskia Waldburger; Lorenz Adrian; Sebastian L Riedel; Peter Neubauer
Journal:  Front Microbiol       Date:  2019-09-13       Impact factor: 5.640

5.  Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.

Authors:  Abdelahhad Barbour; Koshy Philip
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

Review 6.  Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production.

Authors:  Elvis Legala Ongey; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2016-06-07       Impact factor: 5.328

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.